Dyslipidemia Drugs Market - Growth Opportunities in Emerging and Established Markets
Despite the dominance of North America, Asia Pacific is likely to exhibit sustained, rapid growth in the global dyslipidemia drugs market in the coming years. The rising prevalence of ischemic heart conditions and stroke, of which dyslipidemia is a key cause, in dynamic countries such as China and India is likely to ensure sustained demand from the Asia Pacific dyslipidemia drugs market in the coming years.
View full press release